Pilotropic cutaneous T-cell lymphoma without mucinosis. A variant of mycosis fungoides? French Study Group of Cutaneous Lymphomas.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 8651719)

Published in Arch Dermatol on June 01, 1996

Authors

B Vergier1, M Beylot-Barry, C Beylot, A de Mascarel, M Delaunay, A de Muret, L Vaillant, M C Tortel, F Grange, M Bagot, L Laroche, J Wecshler

Author Affiliations

1: Department of Pathology, University of Bordeaux, France.

Articles citing this

Follicular mycosis fungoides - A report of four Indian cases. Indian J Med Paediatr Oncol (2009) 0.84

Articles by these authors

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg (1996) 5.05

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer (1984) 3.94

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. Lancet (1998) 3.84

Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol (2003) 3.66

Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol (2001) 3.41

Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet (1998) 2.89

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut (2001) 2.62

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37

Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34

High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol (1995) 2.00

Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer (1999) 1.96

Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol (1994) 1.90

The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill (2009) 1.90

[Acute generalized exanthematic pustuloses (four cases) (author's transl)]. Ann Dermatol Venereol (1980) 1.81

Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79

Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77

Hepatitis C virus in dermatology. A review. Arch Dermatol (1995) 1.71

Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol (1995) 1.64

[Prevalence of longitudinal melanonychia in the white population]. Ann Dermatol Venereol (1995) 1.62

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood (2000) 1.59

Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol (2012) 1.58

Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci (2000) 1.57

Screening human donor corneas during organ culture for the presence of guttae. Br J Ophthalmol (2001) 1.56

Cutaneous localization of chronic lymphocytic leukemia at the site of chickenpox. J Am Acad Dermatol (1997) 1.54

Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology (1996) 1.52

Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52

Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics (2000) 1.49

Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol (2001) 1.47

Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.46

Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44

[Descriptive epidemiological study of acne on scholar pupils in France during autumn 1996]. Ann Dermatol Venereol (2000) 1.43

Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol (2015) 1.42

Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42

CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol (1996) 1.41

[Necrotizing amebic colitis]. Gastroenterol Clin Biol (1994) 1.40

[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40

Chilblain lupus erythematosus: report of 15 cases. Dermatology (1992) 1.39

[What is the cause of acquired ciliary hypertrichosis in AIDS?]. Ann Dermatol Venereol (1988) 1.39

[Medical activity in a emergency outpatient department dermatology]. Ann Dermatol Venereol (2003) 1.38

An overview of internet biosurveillance. Clin Microbiol Infect (2013) 1.37

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32

Salmonella enterica serovar typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence In vivo. Infect Immun (2000) 1.32

Acute generalized exanthematous pustulosis. Semin Cutan Med Surg (1996) 1.31

Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29

Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut (2003) 1.29

Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol (2001) 1.28

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27

Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23

Donor organ cultured corneal tissue selection before penetrating keratoplasty. Br J Ophthalmol (1998) 1.23

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol (1989) 1.21

Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol (2002) 1.21

A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab (2003) 1.20

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys (1997) 1.20

Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol (1989) 1.17

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13

Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol (1988) 1.13

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13

Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia (2012) 1.11

Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Br J Dermatol (2001) 1.11

Endophthalmitis after Lasiodiplodia theobromae corneal abscess. Graefes Arch Clin Exp Ophthalmol (1997) 1.11

Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol (1997) 1.10

CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am J Surg Pathol (1999) 1.10

What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10

Morphology, histology, and ultrastructure of human C31 organ-cultured corneas. Cornea (1995) 1.09

Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology (2009) 1.08

Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol (1999) 1.08

[Ulcerated necrobiosis lipoidica: successful treatment with topical tacrolimus and hydroxychloroquine]. Ann Dermatol Venereol (2010) 1.07

The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol (2007) 1.06

Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06

Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood (1998) 1.04

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol (1990) 1.04

Resistance of Acanthamoeba to classic DNA extraction methods used for the diagnosis of corneal infections. Br J Ophthalmol (2007) 1.03

Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis? Arch Dermatol (1996) 1.03

Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood (1995) 1.03

Calcifying fibrous pseudotumor of the mediastinum. Ann Thorac Surg (1997) 1.02

Secondary Fuchs's heterochromic cyclitis: a new approach to an old disease. Ophthalmologica (1985) 1.02

Evaluation of the deswelling period in dextran-containing medium after corneal organ culture. Cornea (1997) 1.02